Latest News about AMGN
Recent news which mentions AMGN
From Benzinga
Spotlight on Amgen: Analyzing the Surge in Options Activity
Today 14:15 EST
Tickers
AMGN
From Benzinga
2 Excellent Dividend Stocks to Buy on the Dip
Today 4:32 EST
From Motley Fool
What's Going On With Amgen Stock On Friday?
December 20, 2024
From Benzinga
From Benzinga
These Are the 5 Worst-Performing Stocks in the Dow Jones Industrial Average With 2024 Almost Over
December 12, 2024
From Motley Fool
10 Health Care Stocks Whale Activity In Today's Session
December 11, 2024
From Benzinga
2 No-Brainer Dividend Stocks With Yields Over 3% to Buy in 2025 and Hold for a Decade or Longer
December 09, 2024
From Motley Fool
Should You Buy the 3 Highest-Paying Dividend Stocks in the Dow Jones?
December 07, 2024
From Motley Fool
10 Health Care Stocks Whale Activity In Today's Session
December 05, 2024
From Benzinga
This Healthcare Stock Is a Favorite of Billionaires. But Is It a Buy?
December 05, 2024
From Motley Fool
Eli Lilly Just Got a Bundle of Good News: Time to Buy?
December 04, 2024
From Motley Fool
From Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
December 02, 2024
From Benzinga
This Stock Just Dropped by 12% in 1 Day: Should You Buy the Dip?
December 02, 2024
Tickers
AMGN
From Motley Fool
From Motley Fool
Is Amgen Stock Still a Buy After an Unexpected Reveal of Data?
November 29, 2024
Tickers
AMGN
From Motley Fool
Why Amgen's Weight Loss Result Is a Win for Eli Lilly
November 27, 2024
From Motley Fool
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
November 26, 2024
From Benzinga
Stocks Mixed Ahead Of Fed Minutes, Mexican Peso Tumbles To Over 2-Year Lows On Tariffs Fears: What's Driving Markets Tuesday?
November 26, 2024
From Benzinga
Biden Proposes Medicare, Medicaid Access For Popular Weight-Loss Drugs
November 26, 2024
From Benzinga
Amgen Reveals Data From Closely Watched Monthly Obesity Drug, With Weight Loss Of Up To 20% At One Year And No Plateau
November 26, 2024
From Benzinga
Investing in Pharma Stocks? Check These 3 Things First
November 22, 2024
From Motley Fool
Eli Lilly Stock Tumbles As Kennedy Targets Weight Loss Drugs
November 21, 2024
From Benzinga
Decoding Amgen's Options Activity: What's the Big Picture?
November 20, 2024
Tickers
AMGN
From Benzinga
Silence Therapeutics' Zerlasiran Has Competitive Concerns: Analyst
November 19, 2024
From Benzinga
Neurogene, Nvidia And Other Big Stocks Moving Lower In Monday's Pre-Market Session
November 18, 2024
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.